CCM
ALKS icon

Chiron Capital Management’s Alkermes ALKS Stock Holding History

Chiron Capital Management’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-400
Closed -$7K – 93
2020
Q3 		$7K Buy
+400
New +$7.27K 0.01% 319

Other funds holding ALKS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Chiron Capital Management's ALKS Position: Q4 2020 in Review

Chiron Capital Management sold out of Alkermes (ALKS) in Q4 2020, closing a stake of 400 shares — an estimated $7K sold.

Chiron Capital Management first reported a position in ALKS in Q3 2020 and held it in 1 quarter. The position peaked at $7K in Q3 2020. 215 funds tracked by Wall St. Rank hold ALKS as of Q4 2020.

  • Chiron Capital Management reported no remaining Alkermes position as of Q4 2020 after selling out during the quarter.
  • Chiron Capital Management sold 400 Alkermes shares in Q4 2020, an estimated $7K.
  • Chiron Capital Management first reported a position in Alkermes in Q3 2020 and held it in 1 quarter.
  • Chiron Capital Management's Alkermes position peaked at $7K in Q3 2020.
  • 215 funds tracked by Wall St. Rank held Alkermes as of Q4 2020.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.